These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 25301381)

  • 1. Vasoactive intestinal peptide-deficient mice exhibit reduced pathology in trinitrobenzene sulfonic acid-induced colitis.
    Abad C; Cheung-Lau G; Coûté-Monvoisin AC; Waschek JA
    Neuroimmunomodulation; 2015; 22(3):203-12. PubMed ID: 25301381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered vasoactive intestinal peptides expression in irritable bowel syndrome patients and rats with trinitrobenzene sulfonic acid-induced colitis.
    Del Valle-Pinero AY; Sherwin LB; Anderson EM; Caudle RM; Henderson WA
    World J Gastroenterol; 2015 Jan; 21(1):155-63. PubMed ID: 25574088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-inflammatory effects of carbon monoxide-releasing molecule on trinitrobenzene sulfonic acid-induced colitis in mice.
    Fukuda W; Takagi T; Katada K; Mizushima K; Okayama T; Yoshida N; Kamada K; Uchiyama K; Ishikawa T; Handa O; Konishi H; Yagi N; Ichikawa H; Yoshikawa T; Cepinskas G; Naito Y; Itoh Y
    Dig Dis Sci; 2014 Jun; 59(6):1142-51. PubMed ID: 24442266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPAC1 (vasoactive intestinal peptide (VIP) receptor type 1) G protein-coupled receptor mediation of VIP enhancement of murine experimental colitis.
    Yadav M; Huang MC; Goetzl EJ
    Cell Immunol; 2011; 267(2):124-32. PubMed ID: 21295288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant expressed vasoactive intestinal peptide analogue ameliorates TNBS-induced colitis in rats.
    Xu CL; Guo Y; Qiao L; Ma L; Cheng YY
    World J Gastroenterol; 2018 Feb; 24(6):706-715. PubMed ID: 29456409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VIP deficient mice exhibit resistance to lipopolysaccharide induced endotoxemia with an intrinsic defect in proinflammatory cellular responses.
    Abad C; Tan YV; Cheung-Lau G; Nobuta H; Waschek JA
    PLoS One; 2012; 7(5):e36922. PubMed ID: 22615845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
    Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
    Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diosmetin regulates intestinal immune balance by inhibiting PI3K/AKT signaling to relieve 2, 4, 6-trinitrobenzene sulfonic acid-induced Crohn's disease-like colitis in mice].
    Yang Z; Zhao T; Cheng Y; Zhou Y; Li Y; Wang X; Zhang X; Zuo L; Ge S
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):474-482. PubMed ID: 37087594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses.
    Chen QQ; Yan L; Wang CZ; Wang WH; Shi H; Su BB; Zeng QH; Du HT; Wan J
    World J Gastroenterol; 2013 Aug; 19(29):4702-17. PubMed ID: 23922467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant adeno-associated virus carrying thymosin β
    Zheng XY; Lv YF; Li S; Li Q; Zhang QN; Zhang XT; Hao ZM
    World J Gastroenterol; 2017 Jan; 23(2):242-255. PubMed ID: 28127198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation of carbon monoxide ameliorates TNBS-induced colitis in mice through the inhibition of TNF-α expression.
    Takagi T; Naito Y; Mizushima K; Akagiri S; Suzuki T; Hirata I; Omatsu T; Handa O; Kokura S; Ichikawa H; Yoshikawa T
    Dig Dis Sci; 2010 Oct; 55(10):2797-804. PubMed ID: 20094779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic treatment of experimental colitis with regulatory dendritic cells generated with vasoactive intestinal peptide.
    Gonzalez-Rey E; Delgado M
    Gastroenterology; 2006 Dec; 131(6):1799-811. PubMed ID: 17087944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-6 genetic ablation protects from trinitrobenzene sulfonic acid-induced colitis in mice. Putative effect of antiinflammatory cytokines.
    Gay J; Kokkotou E; O'Brien M; Pothoulakis C; Karalis KP
    Neuroimmunomodulation; 2006; 13(2):114-21. PubMed ID: 17077645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis.
    Guan Q; Ma Y; Hillman CL; Qing G; Ma AG; Weiss CR; Zhou G; Bai A; Warrington RJ; Bernstein CN; Peng Z
    Mol Med; 2011; 17(7-8):646-56. PubMed ID: 21424108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peptide YY 3-36 attenuates trinitrobenzene sulfonic acid-induced colitis in mice by modulating Th1/Th2 differentiation.
    Li Z; Kuang X; Chen T; Shen T; Wu J
    Bioengineered; 2022 Apr; 13(4):10144-10158. PubMed ID: 35443853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-inflammatory activity of a pteridine derivative (4AZA2096) alleviates TNBS-induced colitis in mice.
    Shen C; Dillissen E; Kasran A; Lin Y; Clydesdale G; Sienaert I; Jonghe SD; Gao LJ; Geboes K; Boon L; Rutgeerts P; Ceuppens JL
    J Interferon Cytokine Res; 2006 Aug; 26(8):575-82. PubMed ID: 16881868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of experimental mouse models of inflammatory bowel disease.
    Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
    Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colitogenic role of tumour necrosis factor (TNF) receptors in trinitrobenzene sulphonic acid colitis: TNF-R1 ablation does not affect systemic inflammatory response.
    Yang Y; Wang H; Dou Y; Wang Y; Han G; Wang R; Wang L; Guo R; Xiao H; Li X; Shen B; Shi Y; Chen G; Li Y
    Clin Exp Immunol; 2011 Sep; 165(3):372-82. PubMed ID: 21668898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery from TNBS-induced colitis leads to the resistance to recurrent colitis and an increased ratio of FOXP3 to CD3 mRNA.
    Chen DF; Lu LG; Tao KZ; Lu ZJ; Yuan YZ
    J Dig Dis; 2013 Nov; 14(11):587-95. PubMed ID: 23786412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.